When we asked Philip about his thoughts on what it was like to work
in such an environment, he expressed a sense of contentment in the
freedom for ideation and experimentation—even between colleagues with
such a broad spectrum of expertise and disciplines.
department, I have a lot of colleagues with a myriad
of different backgrounds. It's a very multi-national
department, so it's very inspiring to see the variety
of ideas and creativity that come out of it. We're only 18
people, and I think there are ten different nationalities;
All of us are experts in the field of oral delivery, but
with different competencies in formulation, characterisation
and analysis. You could say we are quite a diverse flock."
Philip went on to describe what it was like to work in a
company where his research was shared across various departments,
spread across multiple areas of the globe. He explained that it made
his sense of purpose even more tangible.
"One of the
great things about the community in Novo Nordisk is
that it is quite easy to communicate across departments.
Even though there are a lot of experts across many
different disciplines, and in many different parts of the
world, we all share a collective sense of purpose. It makes
it possible for people to transcend their specific
knowledge-base and come together to not only deliver
products that make a difference, but also identify new
opportunities that emerge when these different sciences and
New opportunities are definitely what Novo Nordisk is
investing in when it comes to the work of Philip and his
colleagues in Oral Formulation, as the benefits to patients with
diabetes and endocrine disorders are overwhelming. And this patient
benefit is something that resonates deeply with Philip.
In speaking with him, it becomes clear that Philip's vision of
his work and his future is one that is deeply entangled in the same
fundamental value and purpose that has also driven Novo Nordisk for
nearly 100 years—that the patient should be at the centre of
everything that he does.
Learn more about the Oral Formulation Research Department